Simultaneous Recording of Cognitive and Motor Functions After Stroke

Stroke Clinical Trial

— SACSO  

Official title:

Simultaneous Recording of Cognitive and Motor Functions After Stroke : Dissociation of Motor and Cognitive Deficits

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05454748
• Other study ID #: D19-P043
• Status: Completed
• Start date: February 3, 2022
• Est. completion date: June 20, 2023

Study information

• Verified date: June 2022
• Source: Centre Hospitalier St Anne
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Aim: To assess whether a cognitively demanding dual-task has greater impact on manual dexterity in chronic stroke patients than in healthy subjects.

Methods: A visuomotor force-tracking task, combining grip force and oculomotor recordings, will be applied in chronic stroke patients with mild-moderate hemiparesis without clinical cognitive impairments and in age-comparable healthy subjects. The dual-task includes avoiding visual distractors and mental addition of numbers. Dual-task effect is calculated as difference in force control accuracy (dual minus single-task) and as difference in saccade rate (addition of numbers minus visual distractors).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: June 20, 2023
• Est. primary completion date: June 20, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• > 18 years old

• First symptomatic stroke more than 3 months ago

• Box and blocks test score < 52

• Mini Mental State Examination Test > 25

Exclusion Criteria:

• Psychiatric disease

• Risk of Pregnancy

• History of previous stroke

• Disability that may interfere with the performance of tasks

Related Conditions & MeSH terms

• Stroke

Locations

Country	Name	City	State
France	GHU Sainte Anne	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier St Anne

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Saccade inhibition rate	Cross sectional comparison of % of saccades performed towards visual distractors	Baseline measurement (one occasion)